Related Experiment Video

Updated: Jul 12, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

[Hemolytic uremic syndrome. Evaluation of clinical and prognostic factors]

A Palomeque Rico1, X Pastor Durán, C Molinero Egea

  • 1Departamento Pediatría, UCI Pediátrica, Hospital Clínic, Barcelona.

Anales Espanoles De Pediatria
|November 1, 1993
PubMed

Insights

Hemolytic uremic syndrome (HUS) predominantly affects young children, often presenting severely with kidney failure and hypertension. Neurologic impairment and prolonged renal insufficiency are key indicators of poor prognosis in HUS patients.

Area of Science:

  • Pediatric Nephrology
  • Critical Care Medicine
  • Intensive Care Unit (ICU) Studies

Context:

  • Retrospective analysis of 10 pediatric patients admitted to ICU over 7 years.
  • Focus on severe cases of hemolytic uremic syndrome (HUS).
  • Seasonal incidence noted, with higher prevalence during summer months.

Purpose:

  • To describe the clinical characteristics, management, and prognosis of pediatric HUS.
  • To highlight the multisystemic nature of HUS, including extrarenal manifestations.
  • To identify key prognostic indicators in severe HUS cases.

Summary:

  • Mean patient age was 26 months; 90% presented with severe disease, including arterial hypertension and need for peritoneal dialysis.
  • Extrarenal manifestations occurred in 50% of patients, such as seizures (30%), colonic ischemia, and heart failure.
  • Prognostic factors identified include interval of renal insufficiency (>14 days) and neurologic impairment, with the latter being most critical.

Impact:

  • Emphasizes the critical role of early recognition and management of HUS complications.
  • Highlights the importance of monitoring for multisystemic involvement in HUS.
  • Provides crucial insights for predicting outcomes in pediatric HUS, guiding clinical decision-making.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...